Logo image of NMRA

NEUMORA THERAPEUTICS INC (NMRA) Stock Analyst Ratings

NASDAQ:NMRA - Nasdaq - US6409791000 - Common Stock - Currency: USD

1.14  +0.12 (+11.76%)

Buy % Consensus

74

ChartMill assigns a Buy % Consensus number of 74% to NMRA. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 6.73. This target is 490.53% above the current price.
NMRA was analyzed by 14 analysts. The buy percentage consensus is at 74. So analysts seem to be have mildly positive about NMRA.
In the previous month the buy percentage consensus was at a similar level.
NMRA was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
NMRA Historical Analyst RatingsNMRA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10

Price Target & Forecast

Price Low Median Mean High 1.142.024.086.7318.90 - 77.19% 257.89% 490.53% 1,557.89%
NMRA Current Analyst RatingNMRA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5
Up and Down Grades
Date Firm Action Rating
2025-05-13 Needham Reiterate Buy -> Buy
2025-04-10 Needham Reiterate Buy -> Buy
2025-04-02 B of A Securities Downgrade Buy -> Underperform
2025-03-10 Guggenheim Downgrade Buy -> Neutral
2025-03-07 Stifel Downgrade Buy -> Hold
2025-03-07 HC Wainwright & Co. Reiterate Buy -> Buy
2025-03-04 Needham Reiterate Buy -> Buy
2025-03-04 RBC Capital Reiterate Sector Perform -> Sector Perform
2025-03-04 HC Wainwright & Co. Maintains Buy -> Buy
2025-02-14 HC Wainwright & Co. Reiterate Buy -> Buy
2025-01-06 B of A Securities Maintains Buy -> Buy
2025-01-03 HC Wainwright & Co. Reiterate Buy -> Buy
2025-01-02 Needham Reiterate Buy -> Buy
2024-12-16 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-22 RBC Capital Reiterate Outperform -> Outperform
2024-11-13 Needham Reiterate Buy -> Buy
2024-11-13 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-05 JP Morgan Downgrade Overweight -> Neutral
2024-10-18 Needham Reiterate Buy -> Buy
2024-10-01 HC Wainwright & Co. Initiate Buy
2024-09-12 Needham Reiterate Buy -> Buy
2024-09-04 RBC Capital Reiterate Outperform -> Outperform
2024-08-07 Needham Reiterate Buy -> Buy
2024-07-22 Needham Initiate Buy
2024-07-08 Mizuho Initiate Outperform
2024-03-28 RBC Capital Reiterate Outperform -> Outperform
2024-03-18 JP Morgan Maintains Overweight -> Overweight
2024-03-08 RBC Capital Maintains Outperform -> Outperform
2023-11-08 JP Morgan Maintains Overweight -> Overweight
2023-10-10 Guggenheim Initiate Buy